Thermo Fisher completes Athena and Lancaster sales for $940 million

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million.

Athena Diagnostics has been sold to Quest Diagnostics for $740 million. Based in Worcester, Mass., Athena Diagnostics is a leading reference laboratory that provides comprehensive diagnostic testing for neurological and other diseases. The business had approximately $110 million in revenues for full year 2010, has approximately 300 employees and was part of Thermo Fisher's specialty diagnostics business within its Analytical Technologies Segment.

Lancaster Laboratories has been sold to Eurofins Scientific SE for $200 million, subject to a post-closing adjustment. Lancaster Laboratories, based in Lancaster, Pa., provides contract-testing services for pharmaceutical, biopharmaceutical and environmental sciences customers. The business had approximately $115 million in revenues for full year 2010, has approximately 1,100 employees at its operations in the U.S. and Ireland, and was part of Thermo Fisher's biopharma services business within its Laboratory Products and Services Segment.

As previously stated, Athena and Lancaster, combined, contributed $0.11 to Thermo Fisher's 2010 full year adjusted earnings per share, or $0.09 on a GAAP basis. Financial results for both businesses, including historical comparative periods, will be included in discontinued operations beginning with the 2011 first quarter reporting period.

Source: Thermo Fisher Scientific

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, April 30). Thermo Fisher completes Athena and Lancaster sales for $940 million. News-Medical. Retrieved on October 11, 2024 from https://www.news-medical.net/news/20110405/Thermo-Fisher-completes-Athena-and-Lancaster-sales-for-24940-million.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher completes Athena and Lancaster sales for $940 million". News-Medical. 11 October 2024. <https://www.news-medical.net/news/20110405/Thermo-Fisher-completes-Athena-and-Lancaster-sales-for-24940-million.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher completes Athena and Lancaster sales for $940 million". News-Medical. https://www.news-medical.net/news/20110405/Thermo-Fisher-completes-Athena-and-Lancaster-sales-for-24940-million.aspx. (accessed October 11, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher completes Athena and Lancaster sales for $940 million. News-Medical, viewed 11 October 2024, https://www.news-medical.net/news/20110405/Thermo-Fisher-completes-Athena-and-Lancaster-sales-for-24940-million.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Thermo Scientific Neoma Multicollector ICP-MS system delivers reliable isotopic data